Methylprednisolone Sodium Succinate Injection, Powder, Lyophilized, For Solution
Product Images NDC 82094-405

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 82094-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tianjin Kingyork Pharmaceuticals Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (125mg Carton)

Packaging label for methylPREDNISolone Sodium Succinate for Injection, USP 125 mg per vial, lyophilized powder for solution injection. The carton indicates 25 single dose vials intended for intramuscular or intravenous use, manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd in Tianjin, China. The label notes the package does not contain diluent and recommends water for injection or bacteriostatic water as diluents, with benzyl alcohol as a preservative.*

FDA Label Image

Image Description (125mg Vial Revised)

Label for Methylprednisolone Sodium Succinate Injection, USP, 125 mg per vial, a lyophilized powder for injection. The vial is intended for intramuscular or intravenous use as a single dose with disposal of unused portion. The label includes reconstitution instructions and manufacturer details for Tianjin Kingyork Pharmaceuticals Co., Ltd.*

FDA Label Image

Image Description (1g Carton)

Packaging label for Methylprednisolone Sodium Succinate Injection, USP, 1 g per vial, lyophilized powder for solution for intramuscular or intravenous use. The label indicates multi-dose vial and cautions that the package does not contain diluent, recommending bacteriostatic water for injection with benzyl alcohol as preservative. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. Includes storage instructions and space reserved for lot, expiration, serial number, and GTIN data.*

FDA Label Image

Image Description (1g Vial Revised)

Label for Methylprednisolone Sodium Succinate injectable powder, 1 g per vial, for intramuscular or intravenous use. The product is a lyophilized, multi-dose vial manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. Storage instructions specify controlled room temperature 20° to 25°C, protection from light, and reconstitution with 16 mL Bacteriostatic Water for Injection containing benzyl alcohol preservative. The label also notes that the package does not contain diluent and that dosing information is in accompanying prescribing information.*

FDA Label Image

Image Description (2g Carton)

Packaging label for Methylprednisolone Sodium Succinate for Injection, USP, 2 g per vial, a lyophilized powder for intramuscular or intravenous use. The label includes handling instructions, storage conditions at controlled room temperature, and a note that the package does not contain diluent. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (Tianjin, China). The label features the Kingyork logo and states Rx only.*

FDA Label Image

Image Description (2g Vial Revised)

Label for Methylprednisolone Sodium Succinate for Injection, USP, 2 g per vial, lyophilized powder for solution. The label indicates intramuscular or intravenous use, single-dose vial, and storage instructions at 20° to 25°C. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd.*

FDA Label Image

Image Description (40mg Carton)

Packaging label for Methylprednisolone Sodium Succinate for Injection, USP powder for solution. The label shows 40 mg per vial strength in a 25 single dose vial package. The product is indicated for intramuscular or intravenous use, labeled by Tianjin Kingyork Pharmaceuticals Co., Ltd. The label includes storage instructions and states the package does not contain diluent.*

FDA Label Image

Image Description (40mg Vial Revised)

Label for Methylprednisolone Sodium Succinate Injection, USP, 40 mg per vial. The label specifies it is for intramuscular or intravenous use only, single dose vial, with instructions to discard unused portion. It includes reconstitution instructions using 1 mL water or bacteriostatic water for injection. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (Tianjin, China).*

FDA Label Image

Image Description (500mg Carton)

Packaging label for Methylprednisolone Sodium Succinate for Injection, USP 500 mg per vial. The label indicates it is a multi-dose vial intended for intramuscular or intravenous use only. It includes storage instructions, reconstitution directions, and warns that the package does not contain diluent. The labeler is Tianjin Kingyork Pharmaceuticals Co., Ltd, and the NDC is 82094-403-50.*

FDA Label Image

Image Description (500mg Vial Revised)

Label for Methylprednisolone Sodium Succinate for Injection, USP 500 mg per vial, lyophilized powder for injection by Tianjin Kingyork Pharmaceuticals Co., Ltd. The label specifies intramuscular or intravenous use, multi-dose vial, with dosage and storage instructions and a note that the package does not contain diluent.*

FDA Label Image

Image Description (Logo)

FDA Label Image

Image Description (Msssf)

Chemical structure of Methylprednisolone Sodium Succinate, showing the steroid backbone with hydroxyl, methyl, and sodium succinate ester functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.